Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells

Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells

書目詳細資料
Main Authors:	Xue, L, Hardman, C, Chen, W, Batty, P, Ogg, G, Erpenbeck, V, Sandham, D
格式:	Conference item
出版:	American Thoracic Society 2018

相似書籍

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
由: Chen, W, et al.
出版: (2018)

Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
由: Hardman, C, et al.
出版: (2019)

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
由: Sandham, D, et al.
出版: (2019)

Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)
由: Xue, L, et al.
出版: (2019)

Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production
由: Ogg, G, et al.
出版: (2015)

Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production
由: Salimi, M, et al.
出版: (2015)

Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma
由: Veit J. Erpenbeck, et al.
出版: (2016-12-01)

Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial
由: Gonem, S, et al.
出版: (2016)

Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells
由: Xue, L, et al.
出版: (2013)

Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells.
由: Xue, L, et al.
出版: (2014)

The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation
由: Christian Domingo, et al.
出版: (2018-09-01)

Prostaglandin D2 receptor 2 downstream signaling and modulation of type 2 innate lymphoid cells from patients with asthma.
由: Christina Gress, et al.
出版: (2024-01-01)

Fevipiprant reduced airway smooth muscle massin asthmatics via PGD2Receptor antagonism
由: Saunders, R, et al.
出版: (2017)

Fevipiprant reduces airway smooth muscle mass in asthmatics via PGD2 receptor antagonism
由: Saunders, R, et al.
出版: (2017)

The roles of type 2 cytotoxic T cells in inflammation, tissue remodeling, and prostaglandin (PG) D2 production are attenuated by PGD2 receptor 2 antagonism
由: Chen, W, et al.
出版: (2021)

Proallergic cytokines and group 2 innate lymphoid cells in allergic nasal diseases
由: Kazufumi Matsushita, et al.
出版: (2015-07-01)

CD1a presentation of endogenous antigens by group 2 innate lymphoid cells
由: Hardman, C, et al.
出版: (2017)

IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent
由: Hardman, CS, et al.
出版: (2021)

Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2.
由: Armer, R, et al.
出版: (2005)

Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells
由: Luo, J, et al.
出版: (2019)

Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor
由: Rojas Monica A, et al.
出版: (2009-02-01)

Cytometric gating stringency impacts on studies of type 2 innate lymphoid cells in asthma
由: Hinks, T, et al.
出版: (2017)

The role of type 2 innate lymphoid cells in the pathogenesis of atopic dermatitis
由: Salimi, M, et al.
出版: (2014)

Group 2 innate lymphoid cells and asthma
由: Hiroki Kabata, et al.
出版: (2015-07-01)

Pharmacological characterisation of CR6086, a potent prostaglandin E2 receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug
由: Gianfranco Caselli, et al.
出版: (2018-03-01)

Dendritic Cell Vaccines Impact the Type 2 Innate Lymphoid Cell Population and Their Cytokine Generation in Mice
由: Lily Chan, et al.
出版: (2023-10-01)

Fully human antagonistic antibodies against CCR4 potently inhibit cell signaling and chemotaxis.
由: Urs B Hagemann, et al.
出版: (2014-01-01)

Cytokine Networks between Innate Lymphoid Cells and Myeloid Cells
由: Arthur Mortha, et al.
出版: (2018-02-01)

Reduction of circulating innate lymphoid cell progenitors results in impaired cytokine production by innate lymphoid cells in patients with lupus nephritis
由: Seungwon Ryu, et al.
出版: (2020-03-01)

Cysteinyl leukotriene E4 activates human ILC2s and enhances the effect of prostaglandin D2 and epithelial cytokines
由: Salimi, M, et al.
出版: (2017)

Group 2 Innate Lymphoid Cells in Allergic Rhinitis
由: Wang S, et al.
出版: (2024-11-01)

Group 2 innate lymphoid cells and their surrounding environment
由: Maiko Naito, et al.
出版: (2023-03-01)

Group 2 innate lymphoid cells in human asthma
由: Arifumi Iwata, et al.
出版: (2023-04-01)

Type 2 Innate Lymphoid Cells: Protectors in Type 2 Diabetes
由: Jacob D. Painter, et al.
出版: (2021-08-01)

Changes in type 2 innate lymphoid cells and serum cytokines in sublingual immunotherapy in pediatric patients with allergic rhinitis
由: Xiaoqiang Wang, et al.
出版: (2023-01-01)

Leukotriene E4 activates human Th2 cells for exaggerated proinflammatory cytokine production in response to prostaglandin D2.
由: Xue, L, et al.
出版: (2012)

Prostaglandin D2 amplifies lupus disease through basophil accumulation in lymphoid organs
由: Christophe Pellefigues, et al.
出版: (2018-02-01)

The Functional Role of Group 2 Innate Lymphoid Cells in Asthma
由: Takahiro Matsuyama, et al.
出版: (2023-05-01)

Tissue Resident and Migratory Group 2 Innate Lymphoid Cells
由: Laura Mathä, et al.
出版: (2022-04-01)

Group 2 Innate Lymphoid Cells in Respiratory Allergic Inflammation
由: Sofia Helfrich, et al.
出版: (2019-06-01)